{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:45:44Z","timestamp":1793994344262,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T00:00:00Z","timestamp":1325203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10067-011-1924-x","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T18:56:19Z","timestamp":1325184979000},"page":"563-568","source":"Crossref","is-referenced-by-count":23,"title":["Chilblain lupus induced by TNF-\u03b1 antagonists: a case report and literature review"],"prefix":"10.1007","volume":"31","author":[{"given":"Walter A.","family":"Sifuentes Giraldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ahij\u00f3n Lana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Garc\u00eda Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonz\u00e1lez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"V\u00e1zquez Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,30]]},"reference":[{"issue":"3","key":"1924_CR1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2008.10.060","volume":"61","author":"AE Moustou","year":"2009","unstructured":"Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ (2009) Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 61(3):486\u2013504. doi: 10.1016\/j.jaad.2008.10.060","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1924_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","volume":"301","author":"CD Vedove","year":"2009","unstructured":"Vedove CD, Del Giglio M, Schena D, Girolomoni G (2009) Drug-induced lupus erythematosus. Arch Dermatol Res 301(1):99\u2013105. doi: 10.1007\/s00403-008-0895-5","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"1924_CR3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-008-0942-9","volume":"27","author":"CM Hedrich","year":"2008","unstructured":"Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, Heubner G, Lee-Kirsch MA, Gahr M (2008) Chilblain lupus erythematosus\u2014a review of literature. Clin Rheumatol 27(8):949\u2013954. doi: 10.1007\/s10067-008-0942-9","journal-title":"Clin Rheumatol"},{"key":"1924_CR4","first-page":"115","volume-title":"Lupus Eritematoso Sist\u00e9mico","author":"IHC Bielsa","year":"2009","unstructured":"Bielsa IHC (2009) Manifestaciones cut\u00e1neas. In: Kamashta MVM (ed) Lupus Eritematoso Sist\u00e9mico, Thirdth edn. Caduceo Multimedia S.L, Barcelona, pp 115\u2013126","edition":"Third"},{"issue":"3","key":"1924_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","volume":"9","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Roberto Perez A, Diaz-Lagares C, Cuadrado MJ, Khamashta MA (2010) Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9(3):188\u2013193. doi: 10.1016\/j.autrev.2009.10.003","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1924_CR6","first-page":"401","volume":"26","author":"C Gonnet-Gracia","year":"2008","unstructured":"Gonnet-Gracia C, Barnetche T, Richez C, Blanco P, Dehais J, Schaeverbeke T (2008) Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol 26(3):401\u2013407","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"1924_CR7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1191\/0961203305lu2240rr","volume":"14","author":"L Rycke De","year":"2005","unstructured":"De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F (2005) The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 14(12):931\u2013937","journal-title":"Lupus"},{"issue":"5","key":"1924_CR8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","volume":"50","author":"VL Williams","year":"2011","unstructured":"Williams VL, Cohen PR (2011) TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 50(5):619\u2013625. doi: 10.1111\/j.1365-4632.2011.04871.x","journal-title":"Int J Dermatol"},{"issue":"4","key":"1924_CR9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.2009.09563.x","volume":"162","author":"AE Pink","year":"2010","unstructured":"Pink AE, Fonia A, Allen MH, Smith CH, Barker JN (2010) Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol 162(4):780\u2013785. doi: 10.1111\/j.1365-2133.2009.09563.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"1924_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1590\/S0482-50042010000300003","volume":"50","author":"VS Viana","year":"2010","unstructured":"Viana VS, de Carvalho JF, de Moraes JC, Saad CG, Ribeiro AC, Goncalves C, Bueno C, Vendramini MB, Bonfa E (2010) Autoantibodies in patients with psoriatic arthritis on anti-TNFalpha therapy. Rev Bras Reumatol 50(3):225\u2013234","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"1924_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ibd.21362","volume":"17","author":"F Beigel","year":"2011","unstructured":"Beigel F, Schnitzler F, Paul Laubender R, Pfennig S, Weidinger M, Goke B, Seiderer J, Ochsenkuhn T, Brand S (2011) Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease. Inflamm Bowel Dis 17(1):91\u201398. doi: 10.1002\/ibd.21362","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1924_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","volume":"37","author":"MF Costa","year":"2008","unstructured":"Costa MF, Said NR, Zimmermann B (2008) Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 37(6):381\u2013387. doi: 10.1016\/j.semarthrit.2007.08.003","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1924_CR13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine 86(4):242\u2013251. doi: 10.1097\/MD.0b013e3181441a68","journal-title":"Medicine"},{"issue":"1411","key":"1924_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/bmj.1.1411.58","volume":"1","author":"J Hutchinson","year":"1888","unstructured":"Hutchinson J (1888) Harveian lectures on lupus. Br Med J 1(1411):58\u201363","journal-title":"Br Med J"},{"issue":"9","key":"1924_CR15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/0961203310370048","volume":"19","author":"G Obermoser","year":"2010","unstructured":"Obermoser G, Sontheimer RD, Zelger B (2010) Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 19(9):1050\u20131070. doi: 10.1177\/0961203310370048","journal-title":"Lupus"},{"issue":"6","key":"1924_CR16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0213-9251(02)72585-9","volume":"17","author":"G-H Mar\u00eda","year":"2002","unstructured":"Mar\u00eda G-H, del Rosario GPR, Ricardo SA (2002) Perniosis l\u00fapica. Piel 17(6):254\u2013258","journal-title":"Piel"},{"issue":"1","key":"1924_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/DAD.0b013e3181af1d24","volume":"32","author":"A Boada","year":"2010","unstructured":"Boada A, Bielsa I, Fernandez-Figueras MT, Ferrandiz C (2010) Perniosis: clinical and histopathological analysis. Am J Dermatopathol 32(1):19\u201323. doi: 10.1097\/DAD.0b013e3181af1d24","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"1924_CR18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00005792-200105000-00004","volume":"80","author":"M Viguier","year":"2001","unstructured":"Viguier M, Pinquier L, Cavelier-Balloy B, de la Salmoniere P, Cordoliani F, Flageul B, Morel P, Dubertret L, Bachelez H (2001) Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine 80(3):180\u2013188","journal-title":"Medicine"},{"issue":"4","key":"1924_CR19","first-page":"760","volume":"32","author":"C Richez","year":"2005","unstructured":"Richez C, Dumoulin C, Schaeverbeke T (2005) Infliximab induced chilblain lupus in a patient with rheumatoid arthritis. J Rheumatol 32(4):760\u2013761","journal-title":"J Rheumatol"},{"issue":"6","key":"1924_CR20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","volume":"73","author":"B Saint Marcoux","year":"2006","unstructured":"Saint Marcoux B, De Bandt M (2006) Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73(6):710\u2013713. doi: 10.1016\/j.jbspin.2006.02.010","journal-title":"Joint Bone Spine"},{"issue":"3","key":"1924_CR21","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","volume":"7","author":"M Bandt De","year":"2005","unstructured":"De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X (2005) Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 7(3):R545\u2013R551. doi: 10.1186\/ar1715","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1924_CR22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203308090030","volume":"17","author":"S Muller","year":"2008","unstructured":"Muller S, Dieker J, Tincani A, Meroni PL (2008) Pathogenic anti-nucleosome antibodies. Lupus 17(5):431\u2013436. doi: 10.1177\/0961203308090030","journal-title":"Lupus"},{"key":"1924_CR23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1196\/annals.1398.048","volume":"1109","author":"N Duzgun","year":"2007","unstructured":"Duzgun N, Sahin M, Genc Y, Tutkak H (2007) Antinucleosome antibodies and systemic lupus erythematosus. Ann N Y Acad Sci 1109:421\u2013428. doi: 10.1196\/annals.1398.048","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1924_CR24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.10876","volume":"48","author":"L Rycke De","year":"2003","unstructured":"De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F (2003) Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum 48(4):1015\u20131023. doi: 10.1002\/art.10876","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1924_CR25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2010.09829.x","volume":"163","author":"V Lutz","year":"2010","unstructured":"Lutz V, Cribier B, Lipsker D (2010) Chilblains and antiphospholipid antibodies: report of four cases and review of the literature. Br J Dermatol 163(3):645\u2013646. doi: 10.1111\/j.1365-2133.2010.09829.x","journal-title":"Br J Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1924-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1924-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:53Z","timestamp":1559119913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1924-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,30]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1924-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,30]]}}}